Terminal illness requiring palliative care research hub

A Randomized Open-Label, Parallel-Group, Phase 2, 2-Arm Study to Investigate the Pharmacokinetic Profiles of Midazolam Subcutaneous Injection Compared with Midazolam Intravenous Injection in Adult Male and Female Terminally Ill Patients

This study compares two ways of giving a medicine called midazolam to people with difficult symptoms at the end of their lives. It looks at how the body handles the medicine when given as an injection under the skin versus directly into a vein.